Ryan Baker

1 week ago | firehouse.com | Ryan Baker |Jacob Johnson

Firehouse's Mentor Monday: A Different Outlook on RetirementJacob Johnson talks about retirement from the fire service, and focuses on a shift in perspective about how retirement ceremonies are also for the families of the first responder. Jacob Johnson talks about retirement from the fire service, and focuses on a shift in perspective about how retirement ceremonies are also for the families of the first responder.

2 weeks ago | firehouse.com | Ryan Baker |Jacob Johnson

Firehouse's Mentor Monday: Experiences vs. CertificationsThis week Chief Johnson discusses the importance and difference of having experience vs certifications for promotional requirements. This week Chief Johnson discusses the importance and difference of having experience vs certifications for promotional requirements. He defines the difference between years of tenure and how it correlates to experience based on another viewer question.

3 weeks ago | businesswire.com | Ryan Baker

CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced the acceptance of six scientific abstracts at the European Academy of Allergy and Clinical Immunology (EAACI) Congress 2025 taking place in Glasgow, United Kingdom from June 13–16, 2025. Details are as follows:Friday, June 13Potential for Sebetralstat to Address Pseudo-allergic Reaction Burden Secondary to Icatibant in HAE (D1.324): Sally L. Hampton, Paul K. Audhya, Michael D.

3 weeks ago | nbcwashington.com | Ryan Baker

Michael Siluk | UCG | Universal Images Group | Getty ImagesAmerica has a new favorite grill and bar chain. For the first time, Chili's overtook Applebee's in terms of U.S. systemwide sales in 2024, according to Technomic. Data from the restaurant tracking firm shows that from 2021 to 2024, Chili's grew U.S. sales from about $3.6 billion to $4.6 billion, while Applebee's $4.1 billion U.S. sales were about flat over that same time period.

3 weeks ago | businesswire.com | Ryan Baker

–Attack progression halted in median 19.8 minutes after treatment with sebetralstat in both KONFIDENT and KONFIDENT-S trials––Sebetralstat data demonstrated rapid relief and resolution of severe HAE attacks– CAMBRIDGE, Mass. & SALISBURY, England--(BUSINESS WIRE)--KalVista Pharmaceuticals, Inc.